期刊文献+

远程血压综合管理模式的研究进展

Research progress of remote comprehensive blood pressure management model
下载PDF
导出
摘要 随着互联网及智能设备的不断发展,远程医疗已得到广泛应用,在高血压的诊断和治疗过程中也发挥了重要作用。现有多种可穿戴设备已应用于远程血压监测,并依托于远程医疗平台,可对患者进行远程血压综合管理。与传统的门诊随访管理模式相比,远程血压综合管理模式可降低患者的治疗成本,提高依从性,有效改善血压控制。但与此同时,远程血压监测仍存在一些不足之处,如隐私安全问题、法律政策不健全、系统平台使用成本较高等。本文从高血压流行病学、远程医疗模式、远程血压监测的应用以及发展前景等方面展开综述。 With the rapid advancement of the Internet and smart devices,telemedicine has become extensively utilized and plays a crucial role in the diagnosis and treatment of hypertension.Various wearable devices have been employed for remote monitoring of blood pressure.Through the telemedicine platform,patients can be remotely managed with integrated blood pressure management.In comparison to the traditional outpatient follow-up model,the integrated remote blood pressure management model offers advantages such as reduced treatment costs,improved compliance,and enhanced blood pressure control.However,there are still some drawbacks to remote blood pressure monitoring,including concerns regarding privacy and security,inadequate legal policies,and the high cost associated with using the system platform.This article reviews the epidemiology of hypertension,telemedicine model,application and development prospect of remote blood pressure monitoring.
作者 陈诗语 邓玮 CHEN Shiyu;DENG Wei(Department of General Practice,the Second Affiliated Hospital of Chongqing Medical University,Chongqing401336,China)
出处 《中国当代医药》 CAS 2024年第10期185-189,共5页 China Modern Medicine
基金 重庆市技术创新与应用发展专项重点项目(CST C2021jscx-gksb-N0016) 重庆市体育局科研项目(C202005) 重庆市科卫联合医学科研项目(2021MSXM094) 重庆医科大学附属第二医院宽仁英才项目(kryc-gg-2113)。
关键词 高血压 远程医疗 血压监测 移动健康 Hypertension Telemedicine Blood pressure monitoring Mobile health
  • 相关文献

参考文献12

二级参考文献115

  • 1刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1221
  • 2刘翔,朱士俊,李信春.我国远程医疗发展现状、难点和对策分析[J].中国医院,2004,8(6):8-11. 被引量:37
  • 3张玉凌.远洋货轮船员急症电报会诊260例病种分析[J].中华航海医学杂志,1996,3(4):226-227. 被引量:11
  • 4沈逸君.开发远程医疗会诊系统是医疗扶贫的一个好方法[J].中国卫生事业管理,1997,13(6):330-331. 被引量:2
  • 5LI S L 2010 Chinese guidelines for the management of hyperten- sion [ J ]. Chin J Hypertension, 2011,19 (8) :701-743.
  • 6WANG J, ZHANG- L, WANG F, et al. Prevalence, awareness, treatment, and control of hypertension in China: Results from a national survey [J]. Am J Hypertens, 2014, 27 ( 11 ) : 1355-1361.
  • 7GWADRY-SRIDHAR F H, MANIAS E, LAL L,et al. Impact of interventions on medication adherence and blood pressure control in patients with essential hypertension :A systematic review by the ISPOR medication adherence and persistence special interest group[J]. Value Health, 2013, 16(5) :863-871.
  • 8DE GEEST S, RUPPAR T, BERBEN L,et al. Medication non- adherence as a critical factor in the management of presumed re- sistant hypertension : A narrative review [J]. Euro Intervention, 2014, 9(9) :1102-1109.
  • 9GRANGER B B, SWEDBERG K, EKMAN I,et al. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme : Double-blind, randomised, controlled chnical trial[ J]. Lancet, 2005, 366(9502) :2005-2011.
  • 10OSTERBERG L, BLASCHKE T. Adherence to medication[J]. N Engl J Med, 2005, 353(5) :487-497.

共引文献5521

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部